Carrimycin in the treatment of acute promyelocytic leukemia combined with pulmonary tuberculosis: A case report

doi:10.12998/wjcc.v12.i3.623

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2224)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series.

Item

Count

PDF

118

WORD

HTML

1152

Figures (1-3)

227

Sum=1515

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

113

Download

503

Sum=616

Jan 26, 2024 (publication date) through Jan 4, 2025

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Jan 26, 2024; 12(3): 623-629
Published online Jan 26, 2024. doi: 10.12998/wjcc.v12.i3.623

Full Size Figure Download Figure

Figure 3 The change of patient‘s white blood cells during treatment. The patient’s antibiotics uses: d1: Isoniazid 0.3 qd + rifampin 0.45 qd + ethambutol 0.75 qd; d3-d29: Carrimycin 0.4 qd (d10: chemotherapy); d29-d216: He got acute promyelocytic leukemia clinical complete response after chemotherapy and took isoniazid 0.3 qd + rifampin 0.45 qd + ethambutol 0.75 qd.

Citation: Yang FY, Shao L, Su J, Zhang ZM. Carrimycin in the treatment of acute promyelocytic leukemia combined with pulmonary tuberculosis: A case report. World J Clin Cases 2024; 12(3): 623-629
URL: https://www.wjgnet.com/2307-8960/full/v12/i3/623.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i3.623